Multifaceted roles of TAK1 signaling in cancer
Authors:
- 6 November 2019
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 39 (7) , 1402-1413
Abstract
Context-specific signaling is a prevalent theme in cancer biology wherein individual molecules and pathways can have multiple or even opposite effects depending on the tumor type. TAK1 represents a particularly notable example of such signaling diversity in cancer progression. Originally discovered as a TGF-β-activated kinase, over the years it has been shown to respond to numerous other stimuli to phosphorylate a wide range of downstream targets and elicit distinct cellular responses across cell and tissue types. Here we present a comprehensive review of TAK1 signaling and provide important therapeutic perspectives related to its function in different cancers.Keywords
This publication has 86 references indexed in Scilit:
- Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasisBritish Journal of Cancer, 2012
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon CancersCell, 2012
- The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammationNature Immunology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- TAK1 regulates SCF expression to modulate PKBα activity that protects keratinocytes from ROS-induced apoptosisCell Death & Differentiation, 2011
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- ATM- and NEMO-Dependent ELKS Ubiquitination Coordinates TAK1-Mediated IKK Activation in Response to Genotoxic StressMolecular Cell, 2010
- Immunity, Inflammation, and CancerCell, 2010
- TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-βMolecular Cell, 2008
- TGFβ in CancerCell, 2008